Taking Measure of Countermeasures (Part 1): A Review of Government and Industry Efforts to Protect the Homeland through Accelerated Research, Development, and Acquisition of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

Date: Wednesday, April 13, 2011 Time: 02:00 PM Location: 311 Cannon House Office Building, Washington, DC 20515 Subcommittee: Emergency Preparedness, Response, & Communications (112th Congress) Issue: Health

Witnesses

Ms. Cynthia Bascetta, Managing Director, Health Care, Government Accountability Office
Dr. Segaran P. Pillai, Chief Medical and Science Advisor, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security
Dr. Richard J. Hatchett, Chief Medical Officer and Deputy Director, Strategic Sciences and Management, Department of Health and Human Services
Dr. Gerald W. Parker, Deputy Assistant to the Secretary of Defense, Chemical and Biological Defense, Department of Defense
Ms. Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics, and Diagnostics Policy, Biotechnology Industry Organization
Mr. John M. Clerici, Principal, Tiber Creek Partners LLC
Dr. Daniel Fagbuyi, Medical Director, Disaster Preparedness and Emergency Management, Children's National Medical Center

# # #
Media contact: Adam Comis at (202) 225-9978